HAS2 and neoplasm: It is well known that members of the family of molecules of the HA signaling pathway, like HA synthases (HAS1, HAS2, HAS3), HA receptors and hyaluronidases (mainly HYAL1) are critical determinants of tumor growth and progression [16,17,20].